CBU
VRTX icon

CIBC Bancorp USA’s Vertex Pharmaceuticals VRTX Stock Holding History

CIBC Bancorp USA’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.8M Buy
166,673
+102,721
+161% +$45.5M 0.1% 186
2026
Q1 		$28.6M Buy
+63,952
New +$29.8M 0.04% 310
2025
Q3 		$17.5M Buy
+44,774
New +$18.7M 0.1% 165

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

CIBC Bancorp USA's VRTX Position: Q2 2026 in Review

CIBC Bancorp USA increased its Vertex Pharmaceuticals (VRTX) stake by 161% in Q2 2026, buying an estimated $45.5M and bringing the position to 166,673 shares worth $82.8M. The position accounts for 0.1% of the portfolio, ranked #186.

CIBC Bancorp USA first reported a position in VRTX in Q3 2025 and has held it in 3 quarters since. 1,663 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • CIBC Bancorp USA held 166,673 shares of Vertex Pharmaceuticals worth $82.8M as of Q2 2026.
  • CIBC Bancorp USA bought 102,721 Vertex Pharmaceuticals shares in Q2 2026, an estimated $45.5M.
  • Vertex Pharmaceuticals made up 0.1% of CIBC Bancorp USA's portfolio in Q2 2026, its #186 holding.
  • CIBC Bancorp USA first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 1,663 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.